Hypertrophic Cardiomyopathy Clinical Trial

A Prospective Incident Study of Arrhythmias in Hypertrophic Cardiomyopathy

Summary

The purpose of this research study is to understand more about various heart rhythms (electrical problems) in persons with hypertrophic cardiomyopathy with and without sleep apnea.

View Full Description

Full Description

Adult patients with hypertrophic cardiomyopathy and without known atrial fibrillation or pacemaker/implantable cardiac defibrillation will undergo implantable loop recorder implantation. No direct interventions will be performed. Prospective observation of atrial and ventricular arrhythmia incidence and burden will be assessed, with additional analyses performed based on the presence or absence of obstructive sleep apnea.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Currently or previously enrolled in 17-003514 and 16-009474
Adults age >18 years-old with a diagnosis of hypertrophic cardiomyopathy
Both sexes
Able to consent

Exclusion Criteria:

Vulnerable study population
Known atrial fibrillation or flutter (with the exception of post-operative atrial fibrillation)
Pacemaker/ICD implantation
Pregnancy

Study is for people with:

Hypertrophic Cardiomyopathy

Estimated Enrollment:

260

Study ID:

NCT04112290

Recruitment Status:

Recruiting

Sponsor:

Mayo Clinic

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

Mayo Clinic
Rochester Minnesota, 55905, United States More Info
Nicholas Wozniak
Contact
507-255-8794
[email protected]
Shahid Karim, MB, ChB
Contact
507-422-0763
[email protected]
Jeffrey Geske, M.D.
Principal Investigator
Virend Somers, M.D., Ph.D.
Sub-Investigator
Choudhary Anwar Chahal, Ph.D.
Sub-Investigator
Konstantinos Siontis, M.D.
Sub-Investigator
Shahid Karim, M.B., Ch.B.
Sub-Investigator
Shreyas Venkataraman, M.B.B.S.
Sub-Investigator
Meghna Mansukhani, M.D.
Sub-Investigator
Peter Noseworthy, M.D.
Sub-Investigator
Jan Bukartyk, M.S.
Sub-Investigator
Sean Caples, D.O., M.S.
Sub-Investigator
Yong-Mei Cha, M.D.
Sub-Investigator
Thomas Foley, M.D.
Sub-Investigator
Paul Friedman, M.D.
Sub-Investigator
Bernard Gersh, M.B., Ch.B.
Sub-Investigator
Amar Killu, M.B.B.S.
Sub-Investigator
Grace Lin, M.D.
Sub-Investigator
Rick Nishimura, M.D.
Sub-Investigator
Thomas Olson, Ph.D., M.S.
Sub-Investigator
Steve Ommen, M.D.
Sub-Investigator
Phillip Schulte, Ph.D.
Sub-Investigator
Erik St Louis, M.D.
Sub-Investigator

How clear is this clinincal trial information?

Study is for people with:

Hypertrophic Cardiomyopathy

Estimated Enrollment:

260

Study ID:

NCT04112290

Recruitment Status:

Recruiting

Sponsor:


Mayo Clinic

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.